In this month’s issue of The Journal of Nuclear Medicine, Rahbar et al. present exciting retrospective German multicenter data (12 centers) on the performance of prostate-specific membrane antigen (PSMA)–targeted radioligand therapy (RLT) using 177Lu-PSMA 617 in metastatic castration-resistant
PDF的下载单位、IP信息已删除
(2025-6-4)
唠叨的大门
GingerF
Criminology34
学术文献互助
渡人舟
OK
无极微光
Kao
v0id
秋风
潇洒的惋清
Nole
罗Eason
乌鱼
null
skearthy
Anonymous
昏睡的蟠桃
Sapphire
Syening
皖公网安备34019202002308
